Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Acalabrutinib
Zanubrutinib
NCCN Guidelines for Patients for CLL
ASH: COVID-19 Resources for Managing Blood Cancers
UpToDate
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL